Merck & Co., Inc.
MRK
Rangering i aksjer
#40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Aksjekurs
$145.90
Sist synkronisert: 2026-10-16
Markedsverdi
$359.96B
Endring (1 dag)
0.16%
Endring (1 år)
72.07%
Land
US
Handel Merck & Co., Inc. (MRK)
Kategori
Healthcare
Driftsmargin for Merck & Co., Inc. (MRK)
Driftsmargin per October 2026 TTM: 16.65%
Ifølge Merck & Co., Inc. sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 16.65%. Ved slutten av 2024 hadde selskapet en driftsmargin på 31.51%.
Historikk for driftsmargin for Merck & Co., Inc. fra 2000 til 2026
Driftsmargin ved slutten av hvert år
| År | Driftsmargin | Endre |
|---|---|---|
| 2026 (TTM) | 16.65% | -59.58% |
| 2025 | 41.19% | 30.72% |
| 2024 | 31.51% | 541.75% |
| 2023 | 4.91% | -84.08% |
| 2022 | 30.84% | 13.80% |
| 2021 | 27.10% | 102.84% |
| 2020 | 13.36% | -34.06% |
| 2019 | 20.26% | -4.07% |
| 2018 | 21.12% | 24.68% |
| 2017 | 16.94% | 22.66% |
| 2016 | 13.81% | -27.73% |
| 2015 | 19.11% | 20.80% |
| 2014 | 15.82% | -9.13% |
| 2013 | 17.41% | -16.70% |
| 2012 | 20.90% | 11.88% |
| 2011 | 18.68% | 155.89% |
| 2010 | 7.30% | -50.20% |
| 2009 | 14.66% | -42.53% |
| 2008 | 25.51% | 9.86% |
| 2007 | 23.22% | 42.54% |
| 2006 | 16.29% | -38.81% |
| 2005 | 26.62% | -9.52% |
| 2004 | 29.42% | -22.80% |
| 2003 | 38.11% | -10.08% |
| 2002 | 42.38% | -3.18% |
| 2001 | 43.77% | 94.36% |
| 2000 | 22.52% | 0.00% |
Driftsmargin for lignende selskaper eller konkurrenter
| Selskap | Driftsmargin | Forskjell i driftsmargin | Land |
|---|---|---|---|
| 49.72% | -97.01% |
US
|
|
| 25.70% | -98.46% |
US
|
|
| 29.32% | -98.24% |
US
|
|
| 26.59% | -98.40% |
CH
|
|
| 31.24% | -98.12% |
CH
|
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.